Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „Substances“
Suchtreffer
Begriffe & Kennungen
Copalia · 4.3 · • Hypersensitivity to the active substances, to dihydropyridine derivatives, or to any of the excipients liste
Eintrag öffnenCopalia · 4.5 · Potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium and other substances
Eintrag öffnenCorbilta (previously Levodopa/Carbidopa/Entacapone Sandoz) · 4.3 · - Hypersensitivity to the active substances or to any of the excipients listed in section 6.1. - Severe hepati
Eintrag öffnenCorbilta (previously Levodopa/Carbidopa/Entacapone Sandoz) · 4.5 · Caution should be exercised when the following active substances are administered concomitantly with levodopa
Eintrag öffnenCorbilta (previously Levodopa/Carbidopa/Entacapone Sandoz) · 4.5 · Other active substances: Dopamine receptor antagonists (e.g. some antipsychotics and antiemetics), phenytoin a
Eintrag öffnenDafiro HCT · 4.3 · − Hypersensitivity to the active substances, to other sulphonamide derivatives, to dihydropyridine derivatives
Eintrag öffnenDafiro · 4.3 · • Hypersensitivity to the active substances, to dihydropyridine derivatives, or to any of the excipients liste
Eintrag öffnenDafiro · 4.5 · Potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium and other substances
Eintrag öffnenDarunavir Krka · 4.3 · Co-administration of darunavir with low dose ritonavir, with active substances that are highly dependent on CY
Eintrag öffnenDarunavir Krka · 4.3 · Darunavir boosted with either ritonavir or cobicistat inhibits the elimination of active substances that are h
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.3 · Co-administration of darunavir with low dose ritonavir, with active substances that are highly dependent on CY
Eintrag öffnenDarunavir Viatris (previously Darunavir Mylan) · 4.3 · Darunavir boosted with either ritonavir or cobicistat inhibits the elimination of active substances that are h
Eintrag öffnenDeferasirox Accord · 4.5 · The concomitant administration of deferasirox with substances that have known ulcerogenic potential, such as N
Eintrag öffnenDelstrigo · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenDescovy · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenDescovy · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenDiacomit · 4.5 · As stiripentol inhibited CYP2D6 in vitro at concentrations that are achieved clinically in plasma, substances
Eintrag öffnenDiacomit · 4.5 · As stiripentol inhibited CYP2D6 in vitro at concentrations that are achieved clinically in plasma, substances
Eintrag öffnenDiacomit · 4.5 · As stiripentol inhibited CYP2D6 in vitro at concentrations that are achieved clinically in plasma, substances
Eintrag öffnenDiacomit · 4.5 · As stiripentol inhibited CYP2D6 in vitro at concentrations that are achieved clinically in plasma, substances
Eintrag öffnen